ES526990A0 - Un procedimiento para preparar un adsorbido de medicamento - Google Patents

Un procedimiento para preparar un adsorbido de medicamento

Info

Publication number
ES526990A0
ES526990A0 ES526990A ES526990A ES526990A0 ES 526990 A0 ES526990 A0 ES 526990A0 ES 526990 A ES526990 A ES 526990A ES 526990 A ES526990 A ES 526990A ES 526990 A0 ES526990 A0 ES 526990A0
Authority
ES
Spain
Prior art keywords
magnesium trisilicate
preparing
procedure
adsorbed
medicated product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526990A
Other languages
English (en)
Other versions
ES8607723A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES526990A0 publication Critical patent/ES526990A0/es
Publication of ES8607723A1 publication Critical patent/ES8607723A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heat Treatment Of Steel (AREA)
  • Luminescent Compositions (AREA)
  • External Artificial Organs (AREA)
ES526990A 1983-07-20 1983-11-03 Un procedimiento para preparar un adsorbido de medicamento Expired ES8607723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/516,002 US4581232A (en) 1983-07-20 1983-07-20 Magnesium trisilicate suitable for preparation of medicament adsorbates

Publications (2)

Publication Number Publication Date
ES526990A0 true ES526990A0 (es) 1986-06-01
ES8607723A1 ES8607723A1 (es) 1986-06-01

Family

ID=24053698

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526990A Expired ES8607723A1 (es) 1983-07-20 1983-11-03 Un procedimiento para preparar un adsorbido de medicamento

Country Status (13)

Country Link
US (1) US4581232A (es)
EP (1) EP0132472B1 (es)
JP (1) JPS60112722A (es)
AT (1) ATE44130T1 (es)
AU (1) AU563740B2 (es)
CA (1) CA1207232A (es)
DE (1) DE3380090D1 (es)
DK (1) DK159805C (es)
ES (1) ES8607723A1 (es)
FI (1) FI79785C (es)
IE (1) IE56510B1 (es)
NZ (1) NZ206101A (es)
ZA (1) ZA838080B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4761274A (en) * 1986-03-27 1988-08-02 Warner-Lambert Company Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation
US4758425A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of antiasthmatics with complex magnesium aluminum silicate and their preparation
US4758424A (en) * 1986-03-27 1988-07-19 Warner-Lambert Company Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation
US4711774A (en) * 1986-03-27 1987-12-08 Warner-Lambert Company Medicament adsorbates with complex magnesium aluminum silicate and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4717565A (en) * 1986-03-27 1988-01-05 Warner-Lambert Company Process for the preparation of medicament adsorbates
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US5891801A (en) * 1987-07-17 1999-04-06 Calam And Associates, Inc. Palatable liquid-admininstered oral medicaments for relief of discomfort and flavoring combinations therefor
US5468482A (en) * 1987-07-17 1995-11-21 Calam & Associates, Inc. Palatable orally administered liquid medicaments for relief of discomfort and flavoring combinations therefor
JP2535707Y2 (ja) * 1991-04-05 1997-05-14 日本精工株式会社 リニアガイド装置のストッパ装置
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
KR100759635B1 (ko) * 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
DE60320940D1 (de) * 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
JP2007501218A (ja) * 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
SI1566173T1 (sl) * 2004-02-20 2006-12-31 Mattern Udo Farmacevtska zmes za oralno aplikacijo in postopek njene priprave
NZ555909A (en) * 2004-12-13 2009-11-27 Mcneil Ppc Inc Compositions and methods for reducing the degradation of phenylephrine by oxygen
US20090098192A1 (en) * 2007-10-11 2009-04-16 Fuisz Richard C Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
AU2008311350B2 (en) 2007-10-11 2014-04-03 Philip Morris Products S.A. Smokeless tobacco product
US9125434B2 (en) * 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
WO2009099830A2 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips for immediate release of active ingredients
US20090196908A1 (en) * 2008-01-31 2009-08-06 Der-Yang Lee Edible film-strips with modified release active ingredients
CN110330023B (zh) * 2019-07-17 2020-10-13 云鹏医药集团有限公司 一种三硅酸镁的制备及干燥方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR799950A (fr) * 1935-03-27 1936-06-23 Mutosel Procédé de préparation de silicates complexes de bases organiques
US2881113A (en) * 1957-01-29 1959-04-07 Ortho Pharma Corp Therapeutically active compositions containing amphetamines
US3085942A (en) * 1960-12-28 1963-04-16 Hoffmann La Roche Antitussive compositions and preparation
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3337402A (en) * 1963-09-03 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical composition
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US3449266A (en) * 1964-05-25 1969-06-10 Drackett Co Stabilized solid granular perfume composition
US3272594A (en) * 1965-10-22 1966-09-13 Merck & Co Inc Preparation of magnesium trisilicate
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US3636200A (en) * 1969-06-09 1972-01-18 Hoffmann La Roche Pharmaceutical suspension
GB1236880A (en) * 1969-12-20 1971-06-23 Exp Drugs Company Antacid compositions
DE2217652A1 (de) * 1972-04-12 1973-10-18 Paolo Dr Sorbini Lyophilisierte arzneimittelprodukte und verfahren zu ihrer herstellung
DE2631947B2 (de) * 1976-07-15 1980-11-27 Bayer Ag, 5090 Leverkusen Verwendung von ätherischen ölen und Äthylalkohol
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
IL58462A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a penicillin
JPS5594315A (en) * 1979-01-11 1980-07-17 Taiyo Yakuhin Kogyo Kk Antibacterial drug
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation

Also Published As

Publication number Publication date
FI79785C (fi) 1990-03-12
EP0132472B1 (en) 1989-06-21
ZA838080B (en) 1984-06-27
DK159805C (da) 1991-05-06
FI840615L (fi) 1985-01-21
FI79785B (fi) 1989-11-30
DE3380090D1 (en) 1989-07-27
NZ206101A (en) 1985-09-13
DK553283D0 (da) 1983-12-01
JPS60112722A (ja) 1985-06-19
IE832545L (en) 1985-01-20
IE56510B1 (en) 1991-08-28
ATE44130T1 (de) 1989-07-15
DK553283A (da) 1985-01-21
US4581232A (en) 1986-04-08
AU563740B2 (en) 1987-07-23
JPH0465811B2 (es) 1992-10-21
ES8607723A1 (es) 1986-06-01
AU2068983A (en) 1985-01-24
EP0132472A1 (en) 1985-02-13
CA1207232A (en) 1986-07-08
FI840615A0 (fi) 1984-02-15
DK159805B (da) 1990-12-10

Similar Documents

Publication Publication Date Title
AU563740B2 (en) Magnesium trisilicate adsorbate
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
NZ315645A (en) Ipratropium bromide enantiomer with a prolonged duration of action
AR241864A1 (es) Procedimiento para la preparacion de un medicamento basado en nuevos derivados de insulina.
CA2155200A1 (en) Use of topical anesthetics for the treatment of eosinophil-associated diseases
HUT59313A (en) Process for producing pharmaceutical composition comprising flupirtin as active ingredient and suitable for combatting muscular tensions
AU644094B2 (en) Medicaments
PH27594A (en) Medicaments for the treatment of asthma and other respiratory disorders
EP0401903A3 (en) The use of vanilloids for the treatment of respiratory diseases or disorders
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
FR2555050B1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
CA2139385A1 (en) Products containing g-csf and tnf binding protein
KR890003393A (ko) 복합 인산염 흡착제
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
EP0147185A3 (en) Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine
DE3479728D1 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
EP0338415A3 (en) Use of sulphonylureas in the treatment of oedema
DK552586A (da) Absorberende medicinsk pude og fremgangsmaade til fremstilling heraf
GR3018365T3 (en) Use of 15-deoxyspergualine as a medicament.
EP0416604A3 (en) Paf-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
RU93016030A (ru) Лекарственное средство, стимулирующее гранулоцитарный росток кроветворения при цитостатических миелодепрессиях
EP0173145A3 (en) Reduction of the toxic effects caused by anthraquinone drugs
JPS5329916A (en) Ready absorption oryzanol preparation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060116